Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 504
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
COSOPT FREE BEZ KONZERVAČNÍCH PŘÍSAD 20MG/ML+5MG/ML OPH GTT SOL MDC 120(8X15)X0,2ML
0173404 64/ 265/06-C cosoptfree.pdf cosoptfree.pdf S01ED51 R
COSOPT FREE BEZ KONZERVAČNÍCH PŘÍSAD 20MG/ML+5MG/ML OPH GTT SOL MDC 30(2X15)X0,2ML
0173402 64/ 265/06-C cosoptfree.pdf cosoptfree.pdf S01ED51 R
COSOPT FREE BEZ KONZERVAČNÍCH PŘÍSAD 20MG/ML+5MG/ML OPH GTT SOL MDC 60(4X15)X0,2ML
0173403 64/ 265/06-C cosoptfree.pdf cosoptfree.pdf S01ED51 R
COSOPT FREE BEZ KONZERVAČNÍCH PŘÍSAD 20MG/ML+5MG/ML OPH GTT SOL MDC 120(12X10)X0,2ML
0230364 64/ 265/06-C cosoptfree.pdf cosoptfree.pdf S01ED51 R
COSOPT FREE BEZ KONZERVAČNÍCH PŘÍSAD 20MG/ML+5MG/ML OPH GTT SOL MDC 60(6X10)X0,2ML
0230363 64/ 265/06-C cosoptfree.pdf cosoptfree.pdf S01ED51 R
COSOPT FREE BEZ KONZERVAČNÍCH PŘÍSAD 20MG/ML+5MG/ML OPH GTT SOL MDC 30(3X10)X0,2ML
0230362 64/ 265/06-C cosoptfree.pdf cosoptfree.pdf S01ED51 R
CYSTADROPS 3,8MG/ML OPH GTT SOL 1X5ML+KAPÁTKO
0219361 EU/1/15/1049/001 cystadrops.pdf cystadrops.pdf S01XA21 R
CYSTADROPS 3,8MG/ML OPH GTT SOL 4(4X1)X5ML+4XKAPÁTKO
0255256 EU/1/15/1049/002 cystadrops.pdf cystadrops.pdf S01XA21 R
DEXA-GENTAMICIN 0,3MG/G+5MG/G OPH UNG 2,5G
0163303 64/ 477/99-C dexagentam.pdf dexagentam.pdf S01CA01 R
DEXAMETHASONE SODIUM PHOSPHATE NEWLINE PHARMA 1,5MG/ML OPH GTT SOL MDC 10X0,3ML
0245868 64/ 435/19-C dexamethas.pdf dexamethas.pdf S01BA01 R
DEXAMETHASONE SODIUM PHOSPHATE NEWLINE PHARMA 1,5MG/ML OPH GTT SOL MDC 20X0,3ML
0245869 64/ 435/19-C dexamethas.pdf dexamethas.pdf S01BA01 R
DEXAMETHASONE WZF POLFA 1MG/ML OPH GTT SUS 1X5ML PE
0021698 64/ 160/90-C dexamethas.pdf dexamethas.pdf S01BA01 R
DICLOABAK 1MG/ML OPH GTT SOL 1X10ML
0174005 64/ 110/11-C dicloabak.pdf dicloabak.pdf S01BC03 R
DILURAN 250MG TBL NOB 20
0000113 64/ 405/69-C diluran.pdf diluran.pdf S01EC01 R
DORZOGEN COMBI 20MG/ML+5MG/ML OPH GTT SOL 6X5ML
0233621 64/ 349/11-C dorzogenco.pdf dorzogenco.pdf S01ED51 R
DORZOGEN COMBI 20MG/ML+5MG/ML OPH GTT SOL 1X5ML
0233619 64/ 349/11-C dorzogenco.pdf dorzogenco.pdf S01ED51 R
DORZOGEN COMBI 20MG/ML+5MG/ML OPH GTT SOL 3X5ML
0233620 64/ 349/11-C dorzogenco.pdf dorzogenco.pdf S01ED51 R
DORZOLAMID OLIKLA 20MG/ML OPH GTT SOL 6X5ML
0223692 64/ 217/17-C dorzolamid.pdf dorzolamid.pdf S01EC03 R
DORZOLAMID OLIKLA 20MG/ML OPH GTT SOL 1X5ML
0223690 64/ 217/17-C dorzolamid.pdf dorzolamid.pdf S01EC03 R
DORZOLAMID OLIKLA 20MG/ML OPH GTT SOL 3X5ML
0223691 64/ 217/17-C dorzolamid.pdf dorzolamid.pdf S01EC03 R

‹‹ ‹ 2 3 4 5 6 7 8 9 10 11 12 20 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 25. January 2022 at 00:10
Last update of price and payment data: 1. January 2022 at 00:11